A phase II trial of pembrolizumab plus olaparib for the treatment of patients with persistent/recurrent endometrial cancers.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Maria M Rubinstein, Qin Zhou, Alexia Iasonos, Pier Selenica, Britta Weigelt, Caitlin Kaczynski, Kelsey Higgins, Pooja Shah, Viktoriya Paroder, Ying L. Liu, Sminu Bose, Seth M. Cohen, Angela Green, Rachel N. Grisham, Jason A. Konner, Chrisann Kyi, Roisin Eilish O'Cearbhaill, William P. Tew, Carol Aghajanian, Vicky Makker
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410813438